help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2004-0275
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teli, T.
Right arrow Articles by Grammatopoulos, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teli, T.
Right arrow Articles by Grammatopoulos, D. K.
Molecular Endocrinology 19 (2): 474-490
Copyright © 2005 by The Endocrine Society

Regulation of Corticotropin-Releasing Hormone Receptor Type 1{alpha} Signaling: Structural Determinants for G Protein-Coupled Receptor Kinase-Mediated Phosphorylation and Agonist-Mediated Desensitization

Thalia Teli, Danijela Markovic, Michael A. Levine, Edward W. Hillhouse and Dimitris K. Grammatopoulos

Sir Quinton Hazell Molecular Medicine Research Centre (T.T., D.M., D.K.G.), Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, United Kingdom; Division of Paediatrics (M.A.L.), The Children’s Hospital of The Cleveland Clinic Foundation, Cleveland, Ohio 44195; and The Leeds Institute of Health (E.W.H.), Genetics and Therapeutics, University of Leeds, Leeds LS2 9NL, United Kingdom

Address all correspondence and requests for reprints to: Dr. D.Grammatopoulos, Sir Quinton Hazell Molecular Medicine Research Centre, Department of Biological Sciences, The University of Warwick, Gibbet Hill Road, Coventry CV4 7AL, United Kingdom. E-mail: d.grammatopoulos{at}warwick.ac.uk.

Attenuation of CRH receptor type 1 (CRH-R1) signaling activity might involve desensitization and uncoupling of CRH-R1 from intracellular effectors. We investigated the desensitization of native CRH-R in human myometrial cells from pregnant women and recombinant CRH-R1{alpha} stably overexpressed in human embryonic kidney (HEK) 293 cells. In both cell types, CRH-R1-mediated adenylyl cyclase activation was susceptible to homologous desensitization induced by pretreatment with high concentrations of CRH. Time course studies showed half-maximal desensitization occurring after approximately 40 min of pretreatment and full recovery of CRH-R1{alpha} functional response within 2 h of removal of CRH pretreatment. In HEK 293 cells, desensitization of CRH-R1{alpha} was associated with receptor phosphorylation and subsequent endocytosis. To analyze the mechanism leading to CRH-R1{alpha} desensitization, we overexpressed a truncated ß-arrestin (319–418) and performed coimmunoprecipitation and G protein-coupled receptor kinase (GRK) translocation studies. We found that GRK3 and GRK6 are the main isoforms that interact with CRH-R1{alpha}, and that recruitment of GRK3 requires Gß{gamma}-subunits as well as ß-arrestin. Site-directed mutagenesis of Ser and Thr residues in the CRH-R1{alpha} C terminus, identified Thr399 as important for GRK-induced receptor phosphorylation and desensitization.

We conclude that homologous desensitization of CRH-R1{alpha} involves the coordinated action of multiple GRK isoforms, Gß {gamma} dimers and ß-arrestin. Based on our identification of key amino acid(s) for GRK-dependent phosphorylation, we demonstrate the importance of the CRH-R1{alpha} carboxyl tail for regulation of receptor activity.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
D. Markovic, H. Lehnert, M. A. Levine, and D. K. Grammatopoulos
Structural Determinants Critical for Localization and Signaling within the Seventh Transmembrane Domain of the Type 1 Corticotropin Releasing Hormone Receptor: Lessons from the Receptor Variant R1d
Mol. Endocrinol., November 1, 2008; 22(11): 2505 - 2519.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. Markovic, A. Punn, H. Lehnert, and D. K. Grammatopoulos
Intracellular Mechanisms Regulating Corticotropin-Releasing Hormone Receptor-2{beta} Endocytosis and Interaction with Extracellularly Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase Signaling Cascades
Mol. Endocrinol., March 1, 2008; 22(3): 689 - 706.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. H. Oakley, J. A. Olivares-Reyes, C. C. Hudson, F. Flores-Vega, F. M. Dautzenberg, and R. L. Hauger
Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and beta-arrestin-2 recruitment: a mechanism regulating stress and anxiety responses
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R209 - R222.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Markovic, N. Papadopoulou, T. Teli, H. Randeva, M. A. Levine, E. W. Hillhouse, and D. K. Grammatopoulos
Differential Responses of Corticotropin-Releasing Hormone Receptor Type 1 Variants to Protein Kinase C Phosphorylation
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1032 - 1042.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Punn, M. A. Levine, and D. K. Grammatopoulos
Identification of Signaling Molecules Mediating Corticotropin-Releasing Hormone-R1{alpha}-Mitogen-Activated Protein Kinase (MAPK) Interactions: The Critical Role of Phosphatidylinositol 3-Kinase in Regulating ERK1/2 But Not p38 MAPK Activation
Mol. Endocrinol., December 1, 2006; 20(12): 3179 - 3195.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
E. W. Hillhouse and D. K. Grammatopoulos
The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology
Endocr. Rev., May 1, 2006; 27(3): 260 - 286.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Kageyama, K. Hanada, T. Moriyama, T. Nigawara, S. Sakihara, and T. Suda
G Protein-Coupled Receptor Kinase 2 Involvement in Desensitization of Corticotropin-Releasing Factor (CRF) Receptor Type 1 by CRF in Murine Corticotrophs
Endocrinology, January 1, 2006; 147(1): 441 - 450.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society